Demetra Holding announced a strategic collaboration with Masmec Biomed, an Italian company specializing in advanced surgical navigation systems, artificial intelligence, and high-complexity medical technologies. The partnership pairs Demetra’s expertise in the orthopedic, spine, and neuro sectors with Masmec’s capabilities in biomedical engineering, surgical navigation, and AI to accelerate the adoption of more sophisticated surgical solutions.
Demetra said the collaboration reflects its broader ambition to establish itself as a European platform for clinical and technological innovation, extending beyond traditional medical devices to invest in technologies the company says are redefining surgery itself. Demetra pointed to market analyses showing that surgical navigation and AI-based applications represent one of the fastest-growing segments in the medical technology sector, with significant room for adoption across multiple surgical disciplines.
KEY QUOTES:
“Demetra’s story began in operating rooms, alongside surgeons. That is still where we look to understand the future. A new generation of technologies emerging will make surgery more precise, more predictive, and increasingly personalized. Such a transformation requires a new industrial model, capable of connecting clinical expertise, artificial intelligence, navigation, robotics, and data. Our ambition is not simply to participate in this change, but to help build it.”
Michele Perrino, CEO, Demetra Holding
“Being chosen by Demetra is a great pride for us and confirms the value of the work we have carried out over the years. We share the same vision and ambition: increasingly personalized care enabled by technology that ensures accurate diagnosis, minimally invasive procedures, and an approach centered on patient respect and healthcare system sustainability.”
Daniela Vinci, CEO, Masmec
